He obtained his Ph.D. in biochemistry in 1979. He carried put his postdoctoral studies at the National Cancer Institute, Bethesda, MD, on Ca2+-dependent cellular regulation focusing on calmodulin and protein kinase C. His current research interests includes understanding the oxidative regulation of protein kinase C cancer-preventive agents, particularly selenium, and the preconditioning of stroke by green tea polyphenols.